Select country set
Menu Shopping cart 0,00 Search
Distributed product

Liferiver Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit

  • Regulatory status:RUO
  • Type:RT-qPCR
  • Other names:COVID-19, nCoV
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

New RR-0479-02 25 tests (kit)
PubMed Product Details
Technical Data




  • Liferiver Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit is an in-vitro diagnostics (IVD) test kit approved by TGA
  • The kit is based on real-time RT-PCR technology, for the qualitative detection of SARS-CoV-2 specific RNA. The assay includes a positive control and an internal control.
  • The kit measures simultaneously 3 target genes in a single tube: SARS-CoV-2 gene E, gene N, gene ORF1ab
  • The probes specific for SARS-CoV-2 RNA are labelled with the fluorophore FAM (ORF1ab), HEX/VIC/JOE (gene N), and Cal Red 610/ROX/TEXAS RED (gene E). The probe specific for Internal Control (IC) is labelled with the fluorophore Cy5
  • For use with ABI Prism(R)7500/7900; Bio-Rad CFX96; Rotor GeneTM 6000; SLAN; MIC POC Dx48 Instrument
  • qPCR testing for specific RNA in brancheolar lavage, sputum, swab, and endotracheal aspirate samples


Bronchoalveolar lavage, Sputum, COVID-19, Swab, Endotracheal aspirate


-20±5°C / All reagents can be used till the expiration date indicated on the kit label

Limit of Detection

1×103 copies/ml


The kits are CE-IVD certified and intended for professional use.



  • European Union: for in vitro diagnostic use (CE-IVD)
  • TGA approved, 1st CFDA approved kit!
  • The kit includes Internal Control template, Positive Control and Negative Control
  • Ready-to-use system done in one-step RT-PCR assay

Research topic



The Liferiver Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit is based on real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) technology, for in vitro qualitative simultaneous detection of 3 genes (ORF1ab, N, and E) of SARS-CoV-2 RNA in upper respiratory tract specimens (nasopharyngeal and oropharyngeal extracts) and lower respiratory tract specimens (bronchoalveolar lavage fluid (BALF) and deep cough sputum). It is considered as an aid in the diagnosis of the SARS-CoV-2 infection.

Related Products Docs